Review
doi: 10.1177/1087054711433422.
Epub 2012 Feb 21.
A neuropsychological perspective on attention problems in neurofibromatosis type 1
Affiliations
- PMID: 22354384
- DOI: 10.1177/1087054711433422
Item in Clipboard
Review
A neuropsychological perspective on attention problems in neurofibromatosis type 1
J Atten Disord.
2013 Aug.
Abstract
Cognitive problems are common in children with neurofibromatosis type 1 and they can often complicate treatment. The current literature review examines cognitive functioning in neurofibromatosis type 1, with a specific focus on executive functioning. This includes exploration of how deficits in executive functioning are expressed in children with neurofibromatosis type 1 and how these deficits contrast with ADHD. The value of investigating subcomponents of executive functioning is discussed, as are implications for effective treatment and future research.
Keywords: ADD/ADHD; ADHD; NF1; cognitive functioning; neurofibromatosis.
Similar articles
-
Does attention-deficit-hyperactivity disorder exacerbate executive dysfunction in children with neurofibromatosis type 1?Dev Med Child Neurol. 2012 Oct;54(10):898-904. doi: 10.1111/j.1469-8749.2012.04357.x. Epub 2012 Jul 28. Dev Med Child Neurol. 2012. PMID: 22845611
-
Distinct attentional and executive profiles in neurofibromatosis type 1: Is there difference with primary attention deficit-hyperactivity disorder?Eur J Paediatr Neurol. 2024 Jul;51:93-99. doi: 10.1016/j.ejpn.2024.05.016. Epub 2024 Jun 1. Eur J Paediatr Neurol. 2024. PMID: 38905883
-
Planning deficit in children with neurofibromatosis type 1: a neurocognitive trait independent from attention-deficit hyperactivity disorder (ADHD)?J Child Neurol. 2014 Oct;29(10):1320-6. doi: 10.1177/0883073813517001. Epub 2014 Feb 13. J Child Neurol. 2014. PMID: 24532810
-
[Executive function training in attention deficit hyperactivity disorder].Rev Neurol. 2011 Mar 1;52 Suppl 1:S77-83. Rev Neurol. 2011. PMID: 21365607 Review. Spanish.
-
Attention and executive functions in children with epilepsy: what, why, and what to do.Appl Neuropsychol Child. 2014;3(3):215-25. doi: 10.1080/21622965.2013.839605. Epub 2014 Feb 21. Appl Neuropsychol Child. 2014. PMID: 24559518 Review.
Cited by
-
Cognitive and behavioral functioning in two neurogenetic disorders; how different are these aspects in Duchenne muscular dystrophy and Neurofibromatosis type 1?PLoS One. 2022 Oct 10;17(10):e0275803. doi: 10.1371/journal.pone.0275803. eCollection 2022. PLoS One. 2022. PMID: 36215287 Free PMC article.
-
Attention and Motor Learning in Adult Patients with Neurofibromatosis Type 1.J Atten Disord. 2022 Feb;26(4):563-572. doi: 10.1177/10870547211012035. Epub 2021 May 12. J Atten Disord. 2022. PMID: 33978520 Free PMC article.
-
ADHD in children and youth: Part 1-Etiology, diagnosis, and comorbidity.Paediatr Child Health. 2018 Nov;23(7):447-453. doi: 10.1093/pch/pxy109. Epub 2018 Oct 24. Paediatr Child Health. 2018. PMID: 30681669 Free PMC article. Review.
-
Psychometric Properties of Attention Measures in Young Children with Neurofibromatosis Type 1: Preliminary Findings.J Pediatr Neuropsychol. 2022;8(3):123-136. doi: 10.1007/s40817-022-00129-x. Epub 2022 Aug 23. J Pediatr Neuropsychol. 2022. PMID: 36032331 Free PMC article.
-
Assessing Psychiatric Comorbidity and Pharmacologic Treatment Patterns Among Patients With Neurofibromatosis Type 1.Cureus. 2021 Dec 7;13(12):e20244. doi: 10.7759/cureus.20244. eCollection 2021 Dec. Cureus. 2021. PMID: 35004058 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
